4//SEC Filing
Standridge Brent 4
Accession 0001209191-17-054168
CIK 0001509190other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 6:00 PM ET
Size
5.3 KB
Accession
0001209191-17-054168
Insider Transaction Report
Form 4
Standridge Brent
Chief Operating Officer
Transactions
- Sale
Common Stock
2017-09-25$6.11/sh−10,000$61,127→ 70,267 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.10 to $6.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ARATANA THERAPEUTICS, INC.
CIK 0001509190
Entity typeother
Related Parties
1- filerCIK 0001677981
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 6:00 PM ET
- Size
- 5.3 KB